1469P Efficacy and safety of pembrolizumab/axitinib combination in metastatic renal cell carcinoma (mRCC): A multicentric prospective analysis (ProPAXI study)

Authors :: A. Guida
M. Maruzzo
E. Lai
D. Bimbatti
F. Pierantoni
M. Dionese
C. Caserta
C. Mosillo
M.L. Calandrella
S. Macrini
G. Fornarini
E. Zanardi
A. Damassi
F. Calabrò
L. Cerbone
S. Astore
L. Galli
S. Bracarda
Source :: Annals of Oncology. 33:S1218
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools